Here's What the Street Thinks About Addus HomeCare (ADUS)

​Addus HomeCare Corporation (NASDAQ:ADUS) is one of the Overlooked Small Cap Stocks to Buy Now. Wall Street has a positive opinion on Addus HomeCare Corporation (NASDAQ:ADUS) ahead of its fiscal Q4 2025 earnings, expected to be released on February 24, 2026. Analysts expect the company to post roughly $372.87 million in revenue, along with a GAAP EPS of $1.56.

​On January 7, Clarke Murphy from Truist Financial initiated Addus HomeCare Corporation (NASDAQ:ADUS) with a Buy rating and a $135 price target. Earlier on December 10, Joanna Gajuk from Bank of America Securities also reiterated a Buy rating on the stock with a $147 price target.

​Analysts at BofA noted that the positive rating is based on multiple growth drivers supporting the company’s outlook. The firm highlighted that Addus is expected to benefit from rate increases in Texas, which supports management’s mid-to-high single-digit organic growth target for Personal Care. Moreover, BofA also likes the company’s hiring momentum which is expected to increase turnover rates. The firm highlighted that Addus’s strategic focus on Personal Care acquisitions positions it for future expansion.

​Addus HomeCare Corporation (NASDAQ:ADUS) provides in-home care services across three main segments including Personal Care, Hospice, and Home Health.

While we acknowledge the potential of ADUS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.